[ad_1]
BENGALURU (Reuters) – Indian conglomerate Piramal Enterprises said on Thursday it was demerging its pharmaceutical and financial services businesses and listing them as two separate entities to simplify the corporate structure.
(Reporting by Nallur Sethuraman in Bengaluru; Editing by Krishna Chandra Eluri)
Reuters 2021
|
|
|
|
|
|
|
||||
|
||||
Technical analysis trends PIRAMAL ENTERPRISES LIMITED
| Short Term | Mid-Term | Long Term | |
| Trends | Bullish | Bullish | Bullish |
Income Statement Evolution
|
Sell  Buy |
|
| Mean consensus | BUY |
| Number of Analysts | 5 |
| Last Close Price | 2 841,90 INR |
| Average target price | 3 021,40 INR |
| Spread / Average Target | 6,32% |
[ad_2]
Source link
